Natco Pharma hikes investment in US-based eGenesis to $16.7 million
Natco Pharma Ltd on Monday said it has decided to increase its proposed investment in US-based biotechnology firm eGenesis Inc to USD 16.70 million (around Rs 139 crore) from the previously disclosed amount of USD 14 million. Under the revised structure, NATCO Pharma (Canada) Inc will invest USD 13.70 million, while NATCO Pharma USA LLC will contribute USD 3 million, according to a regulatory filing. The transaction involves cash consideration for purchasing convertible promissory notes bearing…



